Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

11.1%

2 terminated out of 18 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed with results

Key Signals

1 with results83% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (10)
P 1 (4)
P 2 (2)
P 4 (2)

Trial Status

Completed10
Unknown6
Terminated2

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT07555444Not ApplicableCompleted

Evaluation of an Oral Care Kit for Maintaining the Oral Health of Patients Admitted to the Intensive Care Unit

NCT04717765Not ApplicableCompleted

Photobiomodulation in Oral Lesions Resulting From Anti-neoplastic Prevention

NCT05242991Not ApplicableUnknown

Effectiveness of Photobiomodulation Protocols in Radiation-induced Oral Side Effects in H&N Cancer Patients

NCT05759975Not ApplicableUnknown

Effectiveness of Extraoral Photobiomodulation in Management of Oral Adverse Effects in Patients Undergoing HSCT

NCT04239872Phase 1CompletedPrimary

Fluoride Retention in the Mouth of Older Adults

NCT03874572Phase 1Unknown

Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth

NCT03876197Phase 1Unknown

Mesenchymal Stem Cells for Radiation-induced Xerostomia

NCT03151889Not ApplicableCompletedPrimary

Eletric Stimulation for Hipossalivation Induced by Radiotherapy

NCT04323384Not ApplicableUnknown

The Effect of Biotene® on the Symptoms of Xerostomia and Mastication and Swallowing

NCT03601962Not ApplicableTerminated

Effects of Aqualief® in Patients With Xerostomia as Consequence of Radiotherapy for Head and Neck Cancer

NCT03302676Not ApplicableCompleted

The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors

NCT03578900Phase 4Completed

Quality of Life and Sjögren Syndrome

NCT03435328Not ApplicableUnknown

Hyposalivation Response To Transcutaneous Electrical Nerve Stimulation In Diabetic Type 2 Patients

NCT00426543Phase 2Completed

Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome

NCT03049943Not ApplicableCompletedPrimary

Low Level Laser Therapy for Hyposalivation

NCT02677480Phase 1CompletedPrimary

The Effect of Probiotic Streptococci and pH-rising Components on the Oral Microbial Flora

NCT02049112Phase 4Completed

A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study

NCT01165970Phase 2TerminatedPrimary

Effect of Saliva Substitutes on Dental Hard Tissues in Situ

Showing all 18 trials

Research Network

Activity Timeline